-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The link between "bad" cholesterol (LDL-C) and adverse health outcomes such as heart disease and stroke may not be as strong as previously thought, according to new research from the RCSI University of Medicine and Health Sciences
The study, published in JAMA Internal Medicine, questioned the efficacy of statins in lowering LDL-C and thus cardiovascular disease (CVD) risk
Previous research has shown that lowering LDL-C with statins has positive health effects, as reflected in various iterations of expert guidelines for the prevention of cardiovascular disease
The new findings refute this theory, finding that the relationship is not as strong as previously thought
Furthermore, this suggests that the overall benefit of taking statins may be small and vary based on individual risk factors
The lead author of the paper is Dr Paula Byrne from the HRB Centre, a primary care research centre based in the RCSI Division of General Medicine
The researchers continue to recommend that these updated information should be communicated to patients through informed clinical decision-making and updated clinical guidelines and policies